v3.26.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jul. 04, 2026
Jun. 28, 2025
Jul. 04, 2026
Jun. 28, 2025
Jan. 03, 2026
Dec. 28, 2024
Summary of Significant Accounting Policies [Line Items]            
Financing Receivable, Sale $ 132,500 $ 129,100 $ 261,200 $ 254,600    
Financing Receivable, Significant Sales, Transaction Fees 1,400 1,500 2,700 2,900    
Basic:            
Net income $ 387,312 $ 12,661 $ 521,625 $ (13,499)    
Shares (in shares) 158,516,000 158,339,000 158,630,000 158,436,000    
Per Share (in usd per share) $ 2.44 $ 0.08 $ 3.29 $ (0.09)    
Effect of dilutive securities: [Abstract]            
Add: Option shares in the money and dilutive effect of non-vested stock (in shares) 2,527,000 2,467,000 2,710,000 0    
Less: Pro forma treasury shares (in shares) (416,000) (1,072,000) (510,000) 0    
Diluted:            
Net Income $ 387,312 $ 12,661 $ 521,625 $ (13,499)    
Shares (in shares) 160,627,000 159,734,000 160,830,000 158,436,000    
Per Share (in usd per share) $ 2.41 $ 0.08 $ 3.24 $ (0.09)    
Antidilutive Securities [Abstract]            
Cash and cash equivalents $ 160,742   $ 160,742   $ 88,671  
Restricted cash 17,905   17,905   16,686  
Restricted cash included in other long-term assets 86,209   86,209   98,181  
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 264,856 $ 218,709 $ 264,856 $ 218,709 $ 203,538 $ 217,307
Stock Options            
Antidilutive Securities [Abstract]            
Antidilutive securities excluded from computation of earnings per share (in shares) 0 0 0 2,177,039    
Non Vested Stock            
Antidilutive Securities [Abstract]            
Antidilutive securities excluded from computation of earnings per share (in shares) 435,106 497,454 486,030 1,072,630